A2M-AS1, DBH-AS1, and NCBP2-AS2 in breast cancer: expression patterns, CA125-3 association, and a DBH-AS1–NCBP2-AS2 axis
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-11035-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Eman A E Badr und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Menoufia university, Shebeen El-Kom, 32511, Egypt. Hauptthemen laut MEDLINE: Breast Neoplasms, RNA, Long Noncoding, Membrane Proteins, CA-125 Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Breast cancer (BC) accounts for approximately one-third of Cancer cases. It is responsible for nearly 16% of all cancer-related deaths among females. Increasing incidence and high mortality associated with BC has prompted the researchers to investigate the genetic and epigenetic mechanisms of the disease. AIM: This study aims to clarify the epigenetic role of lncRNAs: A2M-AS1, DBH-AS1 and NCBP2-AS2. MATERIALS AND METHODS: This case-control study was conducted on fifty patients with BC. A complete medical history, clinical examination, investigations (including mammography and tumor markers), and gene expression analysis were performed. Tumor and adjacent normal breast tissue samples were obtained from patients who underwent mastectomy, used for RNA extraction and gene expression levels of A2M-AS1, DBH-AS1, and NCBP2-AS2 were quantified using PCR. RESULTS: Each of A2M-AS1, DBH-AS1 and NCBP2-AS2 is significantly overexpressed in tumor cases indicating their involvement in BC etiopathogenesis (P value < 0.001). However, unlike A2M-AS1 and DBH-AS1, NCBP2-AS2 is not significantly associated with clinicopathological characteristics of BC (P value ranging from 0.082. to 0.877). A2M-AS1 and DBH-AS1 are significantly associated with metastatic progressed BC cases P value ranging from (0.001 to 0.025).A2M-AS1 is significantly overexpressed in breast with elevated CA125-3 (P value = 0.030). CONCLUSION: A2M-AS1, DBH-AS1, and NCBP2-AS2 lncRNAs are significantly overexpressed in BC. A2M-AS1 and DBH-AS1 overexpressed in metastatic and progressed cases, while A2M-AS1 is significantly elevated in cases with high CA125-3 levels. Additionally, DBH-AS1 may indirectly regulate NCBP2-AS2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Menoufia university, Shebeen El-Kom, 32511, Egypt.
- Menoufia University Hospital, Shebeen El-Kom, 32511, Egypt. Hager.ahmed18@med.menofia.edu.eg.
- 3Faculty of Applied Health Science Technology, Menoufia National University, Shebeen El-Kom, 32511, Egypt.
- Faculty of Science, Menoufia University, Shebeen El-Kom, 32511, Egypt.
- Bachelor of Applied Health Science Technology, Menoufia University, Shebeen El-Kom, 32511, Egypt.
Zitieren
APA
Badr, E. A. E., Alashkar, H. G., El-Rebey, H. S., Khlosy, E. A. E., Ghobashy, E. A., & Abdelbary, H. M. (2025). A2M-AS1, DBH-AS1, and NCBP2-AS2 in breast cancer: expression patterns, CA125-3 association, and a DBH-AS1–NCBP2-AS2 axis. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11035-8
Vancouver
Badr EAE, Alashkar HG, El-Rebey HS, Khlosy EAE, Ghobashy EA, Abdelbary HM. A2M-AS1, DBH-AS1, and NCBP2-AS2 in breast cancer: expression patterns, CA125-3 association, and a DBH-AS1–NCBP2-AS2 axis. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-11035-8
BibTeX
@article{Badr2025,
author = {Badr, Eman A E and Alashkar, Hagar G and El-Rebey, Hala Said and Khlosy, Eman A E and Ghobashy, Eman Abdel-Rahim and Abdelbary, Hammed Mohamed},
title = {A2M-AS1, DBH-AS1, and NCBP2-AS2 in breast cancer: expression patterns, CA125-3 association, and a DBH-AS1–NCBP2-AS2 axis},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-11035-8}
}
EUVIMED